Matrix Global Advisors
  • Home
  • About
  • News
  • Reports
  • Contact
  • Follow
  • Follow
President Biden’s Student Loan Forgiveness: The Impact on Individuals’ State Taxes

President Biden’s Student Loan Forgiveness: The Impact on Individuals’ State Taxes

Sep 28, 2022 | Op-Eds

President Biden’s Student Loan Forgiveness: The Impact on Individuals’ State Taxes Alex Brill and Grant M. Seiter | AEIdeas In a previous post, we explained how President Joe Biden’s student loan forgiveness plan could result in $4.8 billion in...
President Biden’s Student Loan Forgiveness: The Impact on State Tax Revenues

President Biden’s Student Loan Forgiveness: The Impact on State Tax Revenues

Sep 19, 2022 | Op-Eds

President Biden’s Student Loan Forgiveness: The Impact on State Tax Revenues Alex Brill and Grant M. Seiter | AEIdeas More than 43 million Americans will see their student loan debt partially or completely forgiven under President Biden’s student loan relief...
Q&A: Maura Keefe and Alex Brill Discuss Understanding Drug Rebates and Their Role in Promoting Competition

Q&A: Maura Keefe and Alex Brill Discuss Understanding Drug Rebates and Their Role in Promoting Competition

Aug 25, 2022 | Interviews

Q&A: Maura Keefe and Alex Brill Discuss Understanding Drug Rebates and Their Role in Promoting Competition Alex Brill, a senior fellow at the American Enterprise Institute and CEO of Matrix Global Advisors, recently sat down with CAPD spokesperson Maura Keefe to...
New PCMA Podcast Highlights Importance of Prescription Drug Rebates

New PCMA Podcast Highlights Importance of Prescription Drug Rebates

Aug 16, 2022 | Press Releases

New PCMA Podcast Highlights Importance of Prescription Drug Rebates PCMA released the following press release regarding Alex Brill’s interview on the importance of prescription drug rebates. (Washington, D.C.) — The Pharmaceutical Care Management Association’s...
Updated MGA Report Presents Biosimilar Market Opportunities in Ophthalmology

Updated MGA Report Presents Biosimilar Market Opportunities in Ophthalmology

Jul 14, 2022 | Analysis

Updated MGA Report Presents Biosimilar Market Opportunities in Ophthalmology MGA releases an updated report, “Biosimilar Market Opportunities in Ophthalmology.”  Authored by founder and CEO Alex Brill, the report examines the economics of biologic drugs for...
Page 4 of 52« First«...23456...»Last »
  • Analysis (38)
  • Books (3)
  • Events (15)
  • Interviews (48)
  • News (51)
  • Op-Eds (80)
  • Press Releases (4)
  • Testimony (20)
  • Health Care Workforce Shortages
    Health Care Workforce Shortages: An Updated LookFebruary 21, 2023
  • New MGA Analysis of the Adalimumab Biosimilars Market in the United StatesFebruary 21, 2023
  • Squawk Box tax policy
    MGA’s Alex Brill on CNBC’s Squawk Box Discussing the Recent Tax Policy ProposalFebruary 13, 2023
  • Curb Drug Patent Abuse
    Bipartisan Senate Bill Aims to Curb Drug Patent AbuseFebruary 1, 2023
  • Humira rivals drive down cost
    Humira Rivals Set to Try to Drive Down Cost of Blockbuster DrugJanuary 31, 2023
  • patent thickets lost drug savings
    New Report from MGA Examines the One-Year Cost Savings Lost Due to Patent ThicketsJanuary 26, 2023
  • Biosimilar Coverage in Commercial
    New MGA Analysis of Biosimilar Coverage in Commercial Medical BenefitDecember 8, 2022
  • Narrow House GOP Victory
    Narrow House GOP Victory Should Point Toward Policy Development AgendaDecember 6, 2022
  • Health Care Workforce Shortages
    Don’t Let Pandemic Fatigue Inhibit Pandemic PreparednessNovember 15, 2022
  • Pro-Growth Tax System.
    American Renewal: A Simpler, More Responsible, and Pro-Growth Tax SystemNovember 15, 2022
© Copyright 2022 Matrix Global Advisors | Design By DreamBig Creative
MGA
  • Home
  • About
  • News
  • Reports
  • Contact